Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InflaRx N.V. - Common Stock (NQ:IFRX)

0.9055 +0.0268 (+3.05%)
Streaming Delayed Price Updated: 10:00 AM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InflaRx N.V. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... 
Via Benzinga
Inflarx NV (NASDAQ: IFRX) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
News headline image
Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher ↗
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite dropping around 150 points on Wednesday. The Dow traded up 0.07% to 33,425.80 while the NASDAQ fell 1.27% to 11,972.78.... 
Via Benzinga
News headline image
Why Shares of InflaRx Are Soaring Wednesday ↗
A key EUA from the FDA for the company's COVID-19 therapy gave the stock a jolt. 
Via The Motley Fool
News headline image
InflaRx Scores FDA Emergency Use Nod For COVID Antibody ↗
 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About InflaRx ↗
  InflaRx (NASDAQ:IFRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023 ↗
 
Via Benzinga
News headline image
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today? ↗
Liminal Biosciences (LMNL) stock is taking off on Wednesday as investors react to the company getting an unsolicited transaction proposal. 
Via InvestorPlace
News headline image
FDX Stock: What to Know as FedEx Consolidates Operating Companies ↗
FedEx (FDX) stock is on the move Wednesday after the company announced plans to consolidate some of its operating companies. 
Via InvestorPlace
News headline image
MorphoSys, Nuburu And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded mixed, with the Dow Jones gaining more than 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
InflaRx: Q2 Earnings Insights ↗
  InflaRx (NASDAQ:IFRX) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings InflaRx reported EPS of $0.01. 
Via Benzinga
News headline image
InflaRx Shares Are Flying Higher After Emergency Use Nod Plans For Its COVID-19 Treatment ↗
 
Via Benzinga
News headline image
Why Is InflaRx (IFRX) Stock Up 40% Today? ↗
Today's news that InflaRx plans to apply for FDA emergency-use authorization for its Covid-19 treatment has IFRX stock surging. 
Via InvestorPlace
News headline image
InflaRx (IFRX) Stock Pops as FDA Grants Emergency Use Authorization ↗
InflaRx (IFRX) stock is getting a boost on Wednesday following an update from the FDA concerning its Covid-19 treatment. 
Via InvestorPlace
News headline image
Markets Mixed; US Trade Deficit Widens In February ↗
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.13% to 33,446.10 while the NASDAQ... 
Via Benzinga
News headline image
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗
Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
News headline image
InflaRx Provides Development Update For Vilobelimab In Skin Disorder, COVID-19 ↗
 
Via Benzinga
News headline image
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
From InflaRx N.V.
Via GlobeNewswire
News headline image
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday ↗
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
News headline image
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
News headline image
Crude Oil Drops 1%; General Motors Earnings Miss Views ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Tuesday. 
Via Benzinga
News headline image
Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
News headline image
Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Tuesday. 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
InflaRx's Stock Gains Following FDA Fast Track Status To Skin Disease Drug ↗
The US Food and Drug Administration (FDA) granted a Fast Track designation to InflaRx’s (NASDAQ: IFRX) lead candidate Vilobelimab for the treatment of ulcerative Pyoderma Gangrenosum (PG). 
Via Benzinga
News headline image
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
News headline image
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
News headline image
LiveOne And 24 Stocks Moving Premarket ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 92.9% to $0.2295 in pre-market trading. Allena Pharmaceuticals said it previously entered into at market issuance sales agreement with B. Riley... 
Via Benzinga
News headline image
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday ↗
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.